# Vynca

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vynca

- Industry: Healthcare IT
- Headquarters: Palo Alto, US
- Website: www.vyncahealth.com
- Total disclosed funding: $38M
- Latest round: Series C (Dec 23, 2021)
- Investors on record: 7

## About

Vynca, Inc. delivers digital solutions focused on improving advance care planning and end-of-life healthcare services through its innovative platform, empowering individuals to document their healthcare preferences and enhance communication among care teams.Founded in 2013 in Palo Alto, US, Vynca, Inc. specializes in advance care planning solutions. The company's founders, Rush Bartlett and Ryan Van Wert, have a background in healthcare technology. In December 2021, Vynca raised USD 27.4 mn in SERIES C funding led by Questa Capital Management, with participation from other investors, bringing the total amount raised to USD 27.4 mn and a current valuation of USD 66.95 mn.Vynca Health specializes in digital solutions that improve the management of advance care planning and end-of-life healthcare services. Their primary offering is a comprehensive advance care planning platform that helps individuals document their healthcare preferences and ensures these preferences are honored by healthcare providers. The platform facilitates communication between patients, families, and healthcare professionals. Vynca serves healthcare providers, hospitals, and senior living communities in the United States, addressing the need for effective end-of-life care planning and empowering patients while streamlining workflows for healthcare organizations.Vynca Health generates revenue through a subscription-based model tailored for healthcare providers and organizations. Clients enter agreements for access to Vynca's platform, enabling management of advance care planning. The transaction structures often involve partnerships with healthcare institutions, incorporating Vynca's services into their patient care processes. Specific pricing plans and revenue figures are proprietary and not publicly disclosed, aligning with the company's focus on customized solutions for clients.In December 2021, Vynca, Inc. raised USD 27.4 mn in SERIES C funding to expand its clinical services organization and enhance its technology suite for value-based care programs. The company aims to grow its product offerings and penetrate new markets, with strategies focused on facilitating better patient care experiences and meeting the needs of evolving healthcare models.

## Funding rounds

- Series C, Dec 23, 2021, $27M — OCA Ventures, Generator Ventures, Questa Capital, The 4100 Group, First Trust Capital Management
- Series B, Jun 19, 2019, $10M — OCA Ventures, Ziegler, Generator Ventures, Spectrum Health Ventures, First Trust Capital Management

## Investors

- OCA Ventures (https://capitalatlas.ai/funds/oca-ventures) — Series B, Series C
- Ziegler (https://capitalatlas.ai/funds/ziegler) — Series B
- Generator Ventures (https://capitalatlas.ai/funds/generator-ventures) — Series B, Series C
- Spectrum Health Ventures (https://capitalatlas.ai/funds/spectrum-health-ventures) — Series B
- First Trust Capital Management — Series B, Series C
- Questa Capital (https://capitalatlas.ai/funds/questa-capital) — Series C
- The 4100 Group — Series C